New Report Analyses International Biochip/Microarray Markets

Research and Markets has announced the addition of a new report "Concise Analysis of the International Biochips and Microarrays Market" to their offering.

This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.

Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine

The report provides current share of each segment: market size in 2012 and projected value for the years 2018 and 2023. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics. The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.

Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 86 companies are included along with listing of 114 collaborations between companies. The text is supplemented by 19 tables, 8 figures and 100 references to literature.

Key Topics Covered:

Executive Summary

1. Introduction

2. Biochip and Microarray Technologies

3. Microfluidics-based Biochips and Microarrays

4. Protein Biochips

5. Nanobiotechnology-based Biochips & Microarrays

6. Biochips & Microarrays for Epigenetics

7. Applications of Microarrays in Drug Discovery & Development

8. Biochips for Biomarkers, Molecular Diagnostics & Personalized

9. Markets

10. Companies

11. References

For more information visit http://www.researchandmarkets.com/research/2cs339/biochips_and

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Research and Markets. (2019, February 11). New Report Analyses International Biochip/Microarray Markets. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=29515.

  • MLA

    Research and Markets. "New Report Analyses International Biochip/Microarray Markets". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=29515>.

  • Chicago

    Research and Markets. "New Report Analyses International Biochip/Microarray Markets". AZoNano. https://www.azonano.com/news.aspx?newsID=29515. (accessed November 21, 2024).

  • Harvard

    Research and Markets. 2019. New Report Analyses International Biochip/Microarray Markets. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=29515.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.